First Bancorp’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$169K Sell
1,900
-100
-5% -$9.48K 0.07% 147
2026
Q2
$172K Buy
+2,000
New +$175K 0.07% 152
2025
Q4
– Sell
-2,200
Closed -$217K – 134
2025
Q3
$217K Hold
2,200
– – 0.12% 123
2025
Q2
$201K Sell
2,200
-75
-3% -$7.25K 0.12% 127
2025
Q1
$257K Sell
2,275
-1,870
-45% -$200K 0.17% 109
2024
Q4
$442K Buy
4,145
+2,175
+110% +$233K 0.3% 76
2024
Q3
$213K Hold
1,970
– – 0.15% 119
2024
Q2
$214K Hold
1,970
– – 0.16% 113
2024
Q1
$260K Buy
1,970
+100
+5% +$12.5K 0.2% 99
2023
Q4
$228K Sell
1,870
-75
-4% -$8.37K 0.18% 103
2023
Q3
$218K Hold
1,945
– – 0.19% 103
2023
Q2
$283K Sell
1,945
-175
-8% -$23.8K 0.23% 85
2023
Q1
$274K Buy
2,120
+100
+5% +$12.6K 0.23% 88
2022
Q4
$258K Hold
2,020
– – 0.22% 90
2022
Q3
$211K Buy
+2,020
New +$222K 0.19% 100

Other funds holding ZBH

First Bancorp's ZBH Position: Q3 2026 in Review

First Bancorp reduced its Zimmer Biomet (ZBH) stake by 5% in Q3 2026, selling an estimated $9.48K and leaving 1,900 shares worth $169K. The position accounts for 0.07% of the portfolio, ranked #147.

First Bancorp first reported a position in ZBH in Q3 2022 and has held it in 15 quarters since. The position peaked at $442K in Q4 2024. 278 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • First Bancorp held 1,900 shares of Zimmer Biomet worth $169K as of Q3 2026.
  • First Bancorp sold 100 Zimmer Biomet shares in Q3 2026, an estimated $9.48K.
  • Zimmer Biomet made up 0.07% of First Bancorp's portfolio in Q3 2026, its #147 holding.
  • First Bancorp first reported a position in Zimmer Biomet in Q3 2022 and has held it in 15 quarters since.
  • First Bancorp's Zimmer Biomet position peaked at $442K in Q4 2024.
  • 278 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on First Bancorp's 13F filing for Q3 2026, filed 26 Oct 2026.